Roots Analysis

MARCH 8, 2023

Traditionally, text and images were printed on pharmaceutical products to convey important information. In recent years, the use of smart labels allows the developer to convey a greater amount of information about the product to the consumers, without the need for additional packaging space.

Labelling 52

Labelling Communication Packaging 52

Fuld

DECEMBER 14, 2022

Patent Landscape/Technology Landscape. Provide a comprehensive overview of a sector/technology/product category including insights into its evolution and overall ecosystem to help with strategizing competitive goals. We also provide critical Intellectual Property advice to support strategic decision-making. Freedom-to-Operate.

52

52

pharmaphorum

MARCH 31, 2022

University College Dublin spinout Kinesis Health Technologies, which has developed a range of wearable sensors to assess the physical capabilities of patients, has been bought by US company Linus Health for an undisclosed sum.

Hospitals 105

Hospitals 105

pharmaphorum

DECEMBER 2, 2021

It will focus its efforts initially on neurological diseases like Alzheimer’s and Parkinson’s, using technologies that can measure how disease alters tissues, cells and proteins, with the aim of increasing the success rate of drug discovery and development.

Vaccines 82

Vaccines 82

pharmaphorum

OCTOBER 18, 2022

The agreement will see Biocorp’s Injay device incorporated in UltraSafePlus prefilled syringes, giving them digital connectivity that can be used to gather information such as injection completed, time and date, type of drug, batch number and expiration date – al coded by the manufacturer when the syringe is assembled.

Communication 52

Communication 52

pharmaphorum

OCTOBER 11, 2022

million (around $2 million) in financial support for UK health technology assessment (HTA) agency NICE and medicines regulator MHRA to develop guidance on “appropriate, risk-proportionate regulation of digital mental health products” that will provide structure to the emerging market. The healthcare charity is providing £1.8

109

109

Roots Analysis

MARCH 13, 2023

Digital pathology is a transformative technology that has enabled pathologists to make the shift from visual inspection of tissue samples to automated image analysis. AI-based digital pathology can be used by pathologists to extract features from images and classify them into appropriate categories for diagnosis.

Patient Care 52

Patient Care 52

pharmaphorum

JULY 22, 2022

billion and making it one of the online retail giant’s largest-ever acquisitions – and by far its biggest within the health category. San Francisco-based One Medical covers the last three of those categories as well as brick-and-mortar clinics, which Amazon currently lacks. Opposition to the deal.

105

105

Board Vitals - Pharmacist

JULY 31, 2023

With Adaptive Testing technology, users can create an unlimited number of practice quizzes to get a more accurate measure of their competency level. On your score report, you will see the following information: Percentile Rank Difficulty Band Overall Score Subject Performance What does this information mean?

52

52

ISPE

OCTOBER 27, 2022

Challenges & Opportunities in Emerging Digital Health Technologies. Challenges & Opportunities in Emerging Digital Health Technologies. DHTTs are electronic technology tools intended for use in clinical investigations (inclusive of clinical trial and post-market settings) or clinical practice. Trudy Patterson. Ryan Hoshi.

Health and Personal Care Stores 52

Health and Personal Care Stores FDA Communication Clinic Management 52

PQA

MARCH 28, 2024

Our members include community and specialty pharmacy organizations, pharmacists and other healthcare providers, pharmacies, health plans, pharmacy benefit managers, life sciences, technology vendors, government agencies, health information technology partners, researchers, accrediting organizations and academia.

Specialty Pharmacies 40

Specialty Pharmacies Communication Insurance Pharmaceutical Companies 40

PQA

MARCH 27, 2024

Our members include community and specialty pharmacy organizations, pharmacists and other healthcare providers, pharmacies, health plans, pharmacy benefit managers, life sciences, technology vendors, government agencies, health information technology partners, researchers, accrediting organizations and academia.

Specialty Pharmacies 40

Specialty Pharmacies Communication Insurance Pharmaceutical Companies 40

The FDA Law Blog

FEBRUARY 9, 2024

Baumhardt, Senior Medical Device Regulation Expert — As an end of the year gift, FDA finalized its guidance document, Digital Health Technologies for Remote Data Acquisition in Clinical Investigations , in late December. falls into one of the categories of exempt investigations under 21 C.F.R.

FDA 105

FDA Documentation 105

ISPE

OCTOBER 27, 2022

Challenges & Opportunities in Emerging Digital Health Technologies. Challenges & Opportunities in Emerging Digital Health Technologies. DHTTs are electronic technology tools intended for use in clinical investigations (inclusive of clinical trial and post-market settings) or clinical practice. Trudy Patterson. Ryan Hoshi.

Health and Personal Care Stores 52

Health and Personal Care Stores FDA HIPAA Communication 52

Pharmaceutical Technology

OCTOBER 20, 2022

Pharmaceutical Technology Excellence Rankings - The Verdict. Pharmacy, health and beauty company Walgreens is ranked in our SOCIAL category in the 2022 Pharmaceutical Technology Excellence Rankings. The post IN FOCUS: Walgreens appeared first on Pharmaceutical Technology. HQ ADDRESS: 200 Wilmot Road. United States.

Vaccines 52

Vaccines 52

pharmaphorum

AUGUST 12, 2022

Clariness said (PDF) it will use the self-reported data associating symptoms with environmental impact to further advance its patient insights in asthma and provide better information to patients, sites and sponsors.

52

52

pharmaphorum

SEPTEMBER 29, 2022

The FDA regulates mHealth technologies that are medical devices, but the agency has adopted a risk-based approach to regulating mHealth technologies, such as medical device software. When assessing mHealth technology, the FDA will determine whether an application is either: i. not a medical device, ii. General Wellness Products.

FDA 101

FDA Documentation 101

Roots Analysis

JANUARY 16, 2023

Digital pathology is a transformative technology that has enabled pathologists to make the shift from visual inspection of tissue samples to automated image analysis. AI is being used to analyze images and extract meaningful information from them, to automate tedious tasks, and to create new ways of diagnosing and treating diseases.

Patient Care 40

Patient Care 40

The Checkup by Singlecare

FEBRUARY 8, 2024

Examples of drugs in these different categories include: Eliquis (apixaban) Xarelto (rivaroxaban) Pradaxa (dabigatran) Jantoven (warfarin) Lovenox (enoxaparin) Aspirin Ibuprofen Naprosyn (naproxen) Meloxicam Antidepressants A little-known attribute of numerous antidepressants is their tendency to impair the function of platelet cells.

Labelling 98

Labelling FDA 98

pharmaphorum

SEPTEMBER 28, 2022

A new final guidance document that dropped today updates a 2019 draft guidance and clarifies the categories of clinical decision support software that would not be regulated by FDA as a medical device. “I But stay tuned in that space because this is an example of a new technology that we’re excited about.”.

FDA 135

FDA Documentation 135

ISPE

FEBRUARY 17, 2023

These fall into two categories: Customized products with the same indication and same mode of action. The goal is the ability to transfer the technology. This focuses on the concept of originator and offshoot products leveraging information on file and focusing on distinguishing attributes of offshoot products. Breen, Jr.,

FDA 98

FDA Vaccines 98

pharmaphorum

MARCH 27, 2022

The two companies say they plan to launch a series of Software as a Medical Device (SaMD) companion apps for various diseases, including asthma, chronic obstructive pulmonary disease (COPD) and heart failure, as well as technology for running decentralised clinical trials.

Hospitals 58

Hospitals 58

pharmaphorum

JULY 8, 2022

Hybrid or decentralised clinical trials (DCTs) have gained traction as technology, infrastructure and knowledge have evolved to support their use. New sensor technology revolutionising data collection. Table 1: Digital and sensor technology available for use in clinical trials. Source: Izmailova et al, 2017.

FDA 89

FDA 89

Roots Analysis

JANUARY 28, 2024

Velocity: Big Data needs to be handled promptly as businesses generate data at an unprecedented speed, driven by the growing adoption of Internet of Things (IoT), and technologies, such as RFID tags, sensors, and smart meters are used to deal with the high velocity of data in real-time. It is loosely arranged into categories using meta tags.

Health and Personal Care Stores 40

Health and Personal Care Stores Medical Records Hospitals 40

ISPE

MAY 22, 2023

A preview was given of the new ISPE Drug Shortages Prevention Model in which drug shortage prevention focus areas such as quality and manufacturing, regulatory and technology, and innovation align with ISPE’s Communities of Practice and other resources. Regulatory Supply Chain Drug Short Regulatory

Communication 98

Communication FDA 98

Pharmaceutical Technology

FEBRUARY 22, 2023

While the Supreme Court is unpredictable, Amgen has a chance here, says Jorge Contreras, director of the University of Utah’s Program on Intellectual Property and Technology Law. This is a trade-off between the patentee and the public where the patentee gets temporary exclusivity in exchange for revealing this information, adds Contreras.

FDA 104

FDA 104

pharmaphorum

AUGUST 5, 2021

From here, the binding sites are classified into two categories which determine whether a structure- or ligand-based approach is required. According to a 2021 publication “…recent advancements have made it possible to generate and analyse genome-wide PP I networks en masse by coupling Y2H with next-generation sequencing technology (NGS)”. .

Compounding 126

Compounding Chemotherapy 126

ISPE

OCTOBER 28, 2022

The aim of the pilot was to gain information on how to prepare, execute and report a collaborative hybrid inspection. Dr Gouws indicated that many of the Covid-19 vaccine manufacturers in India had also been inspected by WHO and a similar information sharing approach had been undertaken by WHO. Canada DHPID ).

FDA 97

FDA Vaccines Dosage Documentation 97

pharmaphorum

APRIL 11, 2022

Chris Garabedian, CEO of Xontogeny, describes how his past experiences as CEO of Sarepta Therapeutics have led him on an exploration for technology that can effectively leverage wearable data in clinical trials. We believe that VivoSense is ‘the tip of the spear’ in this category.”. Searching for the right solution.

Pharmaceutical Companies 110

Pharmaceutical Companies Pharmaceutical Companies Packaging 110

pharmaphorum

NOVEMBER 20, 2020

We know that the health category has been changing at a rapid clip, and the global pandemic has acted as a major accelerant of some of those changes”, said Brian Robinson, Global Chief Strategy Officer at HH&Y. You can subscribe to receive updates on the most current information available as the global situation unfolds.

Documentation 52

Documentation Communication Medication Delivery 52

pharmaphorum

OCTOBER 19, 2022

As CVS Health expands into different roles across the healthcare journey, the company earns access to more — and more accurate and up-to-date — patient information. With their enlarged scope, CVS is likely to reduce data silos between segmented networks and increase information-sharing across providers in order to improve patient care.

Communication 52

Communication Insurance Patient Care Vaccines 52

Pharmaceutical Technology

DECEMBER 9, 2022

Pharmaceutical Technology Excellence Rankings – The Verdict. The company is ranked in the M&A, PRODUCT LAUNCHES and RESEARCH AND DEVELOPMENT categories in the 2022 Pharmaceutical Technology Excellence Rankings. M&A – Commended PRODUCT LAUNCHES – Commended RESEARCH AND DEVELOPMENT – Commende d.

Vaccines 52

Vaccines Compounding FDA Packaging 52

pharmaphorum

APRIL 20, 2022

” The deal adds to two other recent acquisitions by Thread in the DCT category. DCTs can also reduce costs and improve the efficiency of trials, say proponents, although concerns have been expressed that their reliance on digital technologies could compound disparities in access to clinical research among some demographics.

Compounding 58

Compounding 58

ISPE

NOVEMBER 21, 2022

However, because the regulatory authorities of Singapore, Malaysia, Indonesia and Thailand also were members of PIC/S, these regulatory authorities could exchange information and rely on inspections of biological and API manufacturers. She said that redacted summaries of these inspection reports were posted on the WHO web site.

FDA 52

FDA Vaccines Dosage Documentation 52

Roots Analysis

FEBRUARY 22, 2024

Wound Care Management: Types of Wounds Based on the severity of the wound and time frame required for healing, wounds can be categorized into two categories, namely acute wounds, and chronic wounds. Several companies have developed and are developing advanced wound care products to overcome these challenges.

40

40

The FDA Law Blog

OCTOBER 18, 2023

The examples include both diagnostic (including in vitro diagnostic) devices and therapeutic devices, since there are significant differences in the types of clinical data that may be needed for these two categories of devices.

FDA 64

FDA Medical Records 64

pharmaphorum

SEPTEMBER 28, 2021

P360 , a leading developer of technology for life sciences companies, today announced that its ZING Communication Module has been enhanced with several new enterprise-grade unified communication features. I still have a stack of business cards with the information of 20-30 different pharmaceutical and medical device reps.

Communication 52

Communication 52